VANCOUVER, Dec. 6 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI,
TSX: ANP), a global specialty pharmaceutical and medical device company, is
scheduled to participate in the RBC 2007 Healthcare Conference, which is being
held December 12-13 in New York, NY.
Tom Bailey, Angiotech's Chief Financial Officer, is scheduled to
participate in a panel discussion on Thursday, December 13, at the Westin New
York Times Square, beginning at approximately 9:00am ET.
A live audio-only webcast will be available to all interested parties on
the company's website, www.angiotech.com under the Investors section.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP),
please visit our website at www.angiotech.com.
For further information:
For further information: Deirdre Neary, Manager, Investor Relations,
Angiotech Pharmaceuticals, Inc., (604) 222-7056, email@example.com